SWX Swiss Exchange - Ypsomed Holding Inc. Opens At CHF 73

The shares of the Swiss manufacturer of injection pens, Ypsomed Holding Inc, were traded in the main segment of the SWX Swiss Exchange for the first time today. The issue price was set yesterday (Tuesday) at CHF 68. The opening price on the SWX stood at CHF 73, corresponding to a market capitalisation of CHF 804 million. Ypsomed belongs not only to the SPI®, but also to the two novel sector-specific SXI Life SCIENCES® and SXI Bio+Medtech® indices, which cover one of Switzerland's most prominent industries.

According to the listing prospectus, of the 11'016'000 registered shares entered in the Swiss Commercial Register, 2'754'126 or 25% of all outstanding shares have been placed with the public. Were the greenshoe option of a further 250,000 to be exercised, the free float could rise to 26.7%. The 3'016'000 shares that have been placed in this round originate from a capital increase in connection with the IPO.

Ypsomed is a medical technology company engaged in the development and manufacture of injection pens and pen needles. Its registered office is in Burgdorf. A 2003 spinoff from the Disetronic Group, Ypsomed now has a workforce of around 800. The company generated revenues of CHF 198.7 million for the 2003 / 2004 financial year (ending 31 March 2004).